307 related articles for article (PubMed ID: 30384342)
1. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
Zhao F; Dave VS; Mar MZ; Perri JR
Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes.
Reindel K; Zhao F; Hughes S; Dave VS
Hosp Pharm; 2017 Dec; 52(11):752-760. PubMed ID: 29276255
[No Abstract] [Full Text] [Related]
3. Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE; Cober MP; Thome T; Rouse E
Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684
[TBL] [Abstract][Full Text] [Related]
4. Stability of extemporaneously prepared cinacalcet oral suspensions.
Thomson K; Hutchinson DJ; Chablani L
Am J Health Syst Pharm; 2018 May; 75(9):e236-e240. PubMed ID: 29691267
[TBL] [Abstract][Full Text] [Related]
5. Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE; Cober MP; Hawkins KA; Julian JD
Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300
[TBL] [Abstract][Full Text] [Related]
6. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
Cober MP; Johnson CE
Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574
[TBL] [Abstract][Full Text] [Related]
7. Stability of extemporaneously prepared rufinamide oral suspensions.
Hutchinson DJ; Liou Y; Best R; Zhao F
Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
[TBL] [Abstract][Full Text] [Related]
8. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.
Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ
Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577
[TBL] [Abstract][Full Text] [Related]
9. Stability study of oral pediatric idebenone suspensions.
Schlatter J; Bourguignon E; Majoul E; Kabiche S; Balde IB; Cisternino S; Fontan JE
Pharm Dev Technol; 2017 Mar; 22(2):296-299. PubMed ID: 27583702
[TBL] [Abstract][Full Text] [Related]
10. Stability of extemporaneously prepared moxifloxacin oral suspensions.
Hutchinson DJ; Johnson CE; Klein KC
Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374
[TBL] [Abstract][Full Text] [Related]
11. Stability of extemporaneously prepared glycopyrrolate oral suspensions.
Cober MP; Johnson CE; Sudekum D; Penprase K
Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869
[TBL] [Abstract][Full Text] [Related]
12. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.
Zhang YP; Trissel LA; Fox JL
Int J Pharm Compd; 2000; 4(1):69-71. PubMed ID: 23985892
[TBL] [Abstract][Full Text] [Related]
13. Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP; Johnson CE; Lee J; Currie K
Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533
[TBL] [Abstract][Full Text] [Related]
14. The stability of quetiapine oral suspension compounded from commercially available tablets.
Tran J; Gervase MA; Evans J; Deville R; Dong X
PLoS One; 2021; 16(8):e0255963. PubMed ID: 34375349
[TBL] [Abstract][Full Text] [Related]
15. Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days.
Svirskis D; Jaffer J; Agarwal P; Khan A; Kaur J; Cheng A; Hanning S
Int J Pharm Compd; 2020; 24(3):246-251. PubMed ID: 32401745
[TBL] [Abstract][Full Text] [Related]
16. Stability of nifedipine in two oral suspensions stored at two temperatures.
Nahata MC; Morosco RS; Willhite EA
J Am Pharm Assoc (Wash); 2002; 42(6):865-7. PubMed ID: 12482010
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide stability in extemporaneously compounded oral suspensions.
Trissel LA; Zhang Y; Koontz SE
Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320
[TBL] [Abstract][Full Text] [Related]
18. Stability of sotalol in two liquid formulations at two temperatures.
Nahata MC; Morosco RS
Ann Pharmacother; 2003 Apr; 37(4):506-9. PubMed ID: 12659604
[TBL] [Abstract][Full Text] [Related]
19. Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions.
Caruthers RL; Johnson CE
Am J Health Syst Pharm; 2007 Jul; 64(14):1513-5. PubMed ID: 17617502
[TBL] [Abstract][Full Text] [Related]
20. Stability of sunitinib in oral suspension.
Navid F; Christensen R; Minkin P; Stewart CF; Furman WL; Baker S
Ann Pharmacother; 2008 Jul; 42(7):962-6. PubMed ID: 18577759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
